AvKARE, LLC recalls AVpak — Atovaquone Oral Suspension, USP 750mg/5mL
- Recall date
- April 1, 2024
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- AvKARE, LLC, AVpak
Why it was recalled
Potential Bacillus cereus contamination — Microbial Contamination
What was recalled
Atovaquone Oral Suspension, USP 750mg/5mL
Read the official recall notice →
Get recall alerts
Free email alert whenever AvKARE, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: AvKARE, LLC, AVpak